GL1X · GenesisL1 explorer

MolNFT v1 · #46708 · protein

Crystal structure of valacyclovir hydrolase S122A mutant

2OCL: “Crystal structure of valacyclovir hydrolase S122A mutant”. X-ray diffraction, 2 ligands (MN, MG), 1 pocket (best druggability 0.67). MolNFT v1 #46708 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2OCL
Type
protein
Length
254 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Valacyclovir hydrolase
EC
3.1.-.-
UniProt
Q86WA6
Ligands
MN, MG
Pockets
1 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AValacyclovir hydrolase (EC 3.1.-.-)protein25445% helix, 21% strandQ86WA6

Ligands and binding sites

  • MN · Manganese (II) ion · metal · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13360.670.8132empty

Compared structures

  • 2OCL · Crystal structure of valacyclovir hydrolase S122A mutant · the same entry in another collection · chain A against A, TM-score 1.00
  • Q86WA6 · AlphaFold monomer V2.0 prediction for valacyclovir hydrolase (Q86WA6) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.